AnodyneWiki

Fenfluramine

Fenfluramine
Fenfluramine
Salts
[]
Fenfluramine hydrochloride
Fenfluramine hydrochloride
Molecular structure drawn from PubChem coordinates
Physical properties
[]
Molecular mass231.26 g/mol [1]
Melting point160-170 [1]
Boiling point108-112 [1]
DecompositionWhen heated to decomp it emits very toxic fumes of fluoride ion and oxides of nitrogen. [1]
Solubility412 mg/L [1]
Predicted LogP3.4 [1]
Structural Identifiers
[]
Molecular formulaC12H16F3N
IUPAC nameN-ethyl-1-[3-(trifluoromethyl)phenyl]propan-2-amine
SMILESCCNC(C)CC1=CC(=CC=C1)C(F)(F)F
InChIInChI=1S/C12H16F3N/c1-3-16-9(2)7-10-5-4-6-11(8-10)12(13,14)15/h4-6,8-9,16H,3,7H2,1-2H3
InChIKeyDBGIVFWFUFKIQN-UHFFFAOYSA-N
CAS number458-24-2
UNII2DS058H2CF
PubChem CID3337
Pharmacokinetics[]
Elimination half-life13–30 hours
Routes of administrationBy mouth

Fenfluramine (also known as Obedrex, Rotondin, Pesos, DL-Fenfluramine, Ponderax PA, Fenfluramina, Acino, Fenfluraminum, (+-)-Fenfluramine or Fenfluramin) is a substance of the amphetamine class.

Chemistry

Salts []

Fenfluramine is typically found in the form of its hydrochloride salt.

 []

Fenfluramine is a racemic mixture of the (optical activity ( + / - )).

Stereoisomers from PubChem

Fenfluramine matches Lipinski's rule of five.

Pharmacology

Mechanism of action []

Dravet syndrome is a complex pediatric encephalopathy characterized by recurrent pharmacoresistant seizures of variable type, delayed development, and in many cases, impairment in speech, language, gait, and other neurocognitive functions. Despite substantial variation in presentation and severity, roughly 80% of patients with Dravet syndrome have mutations in the _SCN1A_ gene, which encodes the alpha subunit of a voltage-gated sodium channel (Na<sub>v</sub>1.1). This channel is predominantly localized in inhibitory GABAergic interneurons as well as in excitatory pyramidal neurons; it is thought that dysfunction of neurotransmission regulation results in the seizures and other corresponding symptoms of Dravet syndrome. Various _in vitro_ and _in vivo_ studies have demonstrated that fenfluramine is capable of acting as an agonist of multiple serotonin receptors including 5-HT<sub>1A</sub>, 5-HT<sub>1D</sub>, 5-HT<sub>2A</sub>, 5-HT<sub>2B</sub>, and 5-HT<sub>2C</sub>, as well as a σ1 receptor antagonist. This is at least partly because fenfluramine, as well as its active metabolite norfenfluramine, can act on sodium-dependent serotonin transporters (SERTs) to reverse transport direction and thereby increase extracellular serotonin levels. However, work in animal models of Dravet syndrome suggest that only the modulation of 5-HT<sub>1D</sub>, 5-HT<sub>2C</sub>, σ1, and possibly 5-HT<sub>2A</sub> receptors of fenfluramine result in the anti-epileptiform activity. Interestingly, 5-HT<sub>2B</sub> receptor agonism, which had previously been associated with cardiac valvulopathy, is not anticipated to have any therapeutic value in Dravet syndrome. Although the exact mechanism by which stimulation/inhibition of various receptors leads to the observed therapeutic benefit is unclear, it is hypothesized to be two-fold. Stimulation of 5-HT<sub>1D</sub> and 5-HT<sub>2C</sub> may result in increased GABAergic neurotransmission, while σ1 receptor antagonism may help to modulate responses to _N_-methyl-D-aspartate (NMDA). [1]

Interactions []

Interaction mechanisms documented in (number of interacting drugs):

metabolism / inhibition / induction231 (2 contraindicated)
metabolism / inhibition / induction168 (5 contraindicated)
metabolism / inhibition / induction79 (2 contraindicated)
inhibition / metabolism / induction76 (3 contraindicated)
shared target55
metabolism / induction / inhibition54 (2 contraindicated)
metabolism / inhibition17
shared target17
shared target15
shared target8
shared target2

 []

  • Brazil: Fenfluramine is a F4.[3]
  • United States: Fenfluramine is Prescription only.
  • European Union: Fenfluramine is Prescription only.[4][5]

See also []

External links []

References []

  1. National Center for Biotechnology Information. PubChem Compound Summary for CID 3337, Fenfluramine. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/3337
  2. U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Fenfluramine. UNII: 2DS058H2CF. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/2DS058H2CF
  3. RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 24 July 2023. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-804-de-24-de-julho-de-2023-498447451
  4. Fintepla EPAR. European Medicines Agency (EMA). 13 October 2020. https://www.ema.europa.eu/en/medicines/human/EPAR/fintepla
  5. Fintepla Product information. Union Register of medicinal products. https://ec.europa.eu/health/documents/community-register/html/h1491.htm

Data sources []

SourceStatusUpdated (UTC)
dosingmissing (no dosing statistics)2026-11-20 13:00:58
drugspromissing (no DrugsPRO reagent data)2026-11-20 13:00:54
erowidmissing (no Erowid substance of that name)2026-11-20 13:00:54
gsrsok2026-11-20 13:00:55
hmdbmissing (hmdb.ca refused automated access to HMDB0252200)2026-11-20 13:00:54
keggok2026-11-20 13:00:58
pubchemok2026-11-20 13:00:52
redditmissing (no r/tripreports posts mention it)2026-11-20 13:00:54
sidermissing (not in SIDER)2026-11-20 13:00:54
structureok2026-11-20 13:00:54
wikipediaok2026-11-20 13:00:54